SI-BONE, Inc. has entered into a Fourth Amendment to its corporate lease, extending the term of its headquarters by one month. The agreement, signed on September 11, 2026, with Landlord BIXBY SPE FINANCE 11, LLC, extends the lease through October 31, 2026. The company will pay a base rent of $43,696 per month for this period and continues to cover its share of operating expenses and taxes.
In other business developments, the company announced a voluntary recall of 98 iFuse TORQ implants. The recall was initiated on August 21, 2026, due to a failure in the tube packaging that acts as a sterile barrier. The affected lots were manufactured between May 4, 2026, and May 15, 2026, and were distributed to the company’s field salesforce and customers.
Of the recalled implants, two had already been implanted in patients. The company has notified the physicians involved, and as of the report date, no infections or adverse events have been reported. The company submitted a report of correction and removal to the U.S. Food and Drug Administration (FDA) on August 31, 2026, recommending the action be classified as a Class II recall.
SI-BONE estimates that approximately 3,900 implants will need to be repackaged and re-sterilized. The company anticipates recording an aggregate gross charge of up to approximately $150,000 in the third and fourth quarters of 2026 related to these costs. The company does not believe its third quarter revenue will be impacted by the recall, as the remaining inventory is quarantined and the company has sufficient on-hand stock to continue operations. The company expects to provide further details on the financial impact when it reports third-quarter results.
